Fog off is now $9.99 Give it a try

Brain Fog Statistics 2026

SureokGo Brain Fog Database Marker Alpha-7X9

Brain Fog: 175 Years of a Silent Epidemic

From Victorian "brain fag" to modern $5 trillion crisis. 100+ statistics. Complete history. Why it's still not a diagnosis. Every condition. The mechanisms. What actually works.

Medically reviewed by Dr. Alexandru-Theodor Amarfei, M.D

Physician with experience in geriatric medicine. Former chief of service during COVID-19. Formulator of FOG OFF.


Last updated February 10, 2026 


1850
Year "brain fag" first coined in Britain
28%
of adults report brain fog (general population)
$5T
annual global cost of brain health disorders
0
ICD codes specifically for "brain fog"

🆕 Live Database: Updated weekly with new research. We will continually add more information and country specific databases for deeper insight. This page contains 100+ individually cited statistics from peer-reviewed sources. Our latest update is South korea

Database compilation BFS-SOKG-2026-Marker-Beta

A Brief History of "Brain Fog"

Brain fog is not a new phenomenon. The experience of mental exhaustion, clouded thinking, and cognitive difficulty has been documented across cultures for millennia. What has changed is how we name it, who we attribute it to, and whether we take it seriously.

1850
"Brain fag" coined by James Tunstall in Britain to describe mental exhaustion from "overstudy" and excessive brain work. First appearance in medical literature. [12] Ayonrinde, International Review of Psychiatry, 2020
1851
Dunglison Medical Lexicon includes "brain-fag" as medical term for cognitive exhaustion. [13] Dunglison, A Dictionary of Medical Science, 1851
1869
"Neurasthenia" coined by American neurologist George Beard. Described as "nervous exhaustion" affecting the educated classes. Called "Americanitis" due to perceived prevalence in fast-paced American society. [14] Beard, Boston Medical and Surgical Journal, 1869
1870s
Class distinction emerges: "Brain fag" becomes associated with working classes; "neurasthenia" reserved for upper classes. Different doctors treat each: asylum alienists for brain fag, neurologists for neurasthenia. [15] Ayonrinde, 2020
1870+
British Empire spread: Term "brain fag" disseminates across colonies. 83,479 newspaper references found between 1870-1960. [16] British Newspaper Archive analysis
1877
S. Weir Mitchell publishes "Fat and Blood" describing the rest cure for nervous exhaustion, which would become the dominant treatment for cognitive complaints. [17] Mitchell, Fat and Blood, 1877
1960
Brain Fag Syndrome: Raymond Prince describes Nigerian students with symptoms of "brain fatigue." Wrongly classified as "culture-bound syndrome" in DSM-IV, despite Victorian British origins. [18] Prince, Journal of Mental Science, 1960
1980
Neurasthenia removed from DSM. Persists in ICD and in Asia as "shenjing shuairuo" (神经衰弱). [19] DSM-III, American Psychiatric Association, 1980
1990s
"Fibro fog" emerges in fibromyalgia communities. "Chemo brain" described in cancer survivors. ME/CFS patients report cognitive dysfunction as primary symptom. [20] Multiple sources
2020
COVID-19 makes "brain fog" mainstream. Long COVID patients report cognitive symptoms. Term enters popular discourse. [21] Lancet, 2020
2021
ICD-10-CM code U09.9 created for "Post COVID-19 condition"—but still no specific brain fog code. [22] WHO ICD-10 Update, 2021
2024
Brain Fog Scale (BFS) validated—first standardized 23-item measure. Blood-brain barrier disruption confirmed in Nature Neuroscience. [23] Debowska et al., 2024; [24] Greene et al., Nature Neuroscience, 2024
2025
Yale study confirms crisis predates COVID. Trends in Neurosciences calls for standardized definition and biomarker development. [25] de Havenon et al., Neurology, 2025; [26] Ross et al., Trends in Neurosciences, 2025

Historical Synonyms for Brain Fog

Throughout history, the same experience has been called: brain fag, neurasthenia, nervous exhaustion, mental fog, clouding of consciousness, fibro fog, chemo brain, and cognitive dysfunction. The terminology changes; the suffering doesn't.

Historical Treatments: From Rest Cure to Brain Tonics

If brain fog is not a new phenomenon, neither are attempts to treat it. Victorian physicians developed elaborate therapies for neurasthenia and "brain fag"—some harmful, some prescient, and some that foreshadowed modern nootropics.

The Rest Cure (1873-1925)

The dominant treatment for mental exhaustion in the late 19th century was the "rest cure," developed by Philadelphia neurologist Silas Weir Mitchell. Originally designed for Civil War veterans with "nervous injuries," Mitchell adapted it for what he called "nervous women, who, as a rule, are thin, and lack blood."

The Rest Cure Protocol

  • Complete bed rest: 6-8 weeks, often longer
  • Isolation: No visitors, no reading, no writing, no intellectual stimulation
  • Force-feeding: Up to 2 quarts of milk daily, sometimes 18+ raw eggs
  • Electrotherapy: Mild electrical stimulation to prevent muscle atrophy
  • Massage: To maintain circulation during immobility

The cure was controversial even then. Charlotte Perkins Gilman's 1892 story "The Yellow Wallpaper" depicted a woman driven to madness by rest cure confinement. Virginia Woolf also underwent and criticized the treatment. A 1998 BMJ paper called for "putting the rest cure to rest—again," noting that enforced inactivity worsens, rather than improves, fatigue syndromes. [27] Wessely, BMJ, 1998

"Brain work having ceased, mental expenditure is reduced to a slight play of emotions and an easy drifting of thought."

— S. Weir Mitchell, "Fat and Blood" (1877) [28]

Brain Tonics and Patent Medicines

For those who couldn't afford the rest cure, the late Victorian era offered an alternative: "brain tonics." These patent medicines promised to restore mental energy and cure neurasthenia through pharmacological means.

$75 Million
Estimated size of U.S. patent medicine industry by 1900
[29] Historical industry estimates
3,000+
Different patent medicine products on the market at the turn of the 20th century
[30] Historical records

Vin Mariani (1863)

The most famous brain tonic was Vin Mariani, a coca wine developed by French chemist Angelo Mariani. Combining Bordeaux wine with coca leaf extract (containing approximately 6-7mg cocaine per ounce), it was endorsed by Pope Leo XIII, Queen Victoria, Thomas Edison, and over 8,000 physicians. [31] Mariani Album, historical records

Pemberton's "Brain Tonic" (1886)

Pharmacist John Pemberton developed "French Wine Coca" as a treatment for "neurasthenia, nervous afflictions, and all nervous troubles." When Atlanta enacted prohibition laws, he reformulated it without alcohol—creating Coca-Cola, initially marketed as "a valuable Brain Tonic, and a cure for all nervous affections." [32] Coca-Cola Company archives

Ingredients That Persisted

Not all Victorian remedies were quackery. Several ingredients from 19th-century tonics appear in modern nootropic formulations:

Victorian Ingredient Modern Form Current Evidence Source
Kola nut / caffeine Caffeine supplements Well-established cognitive enhancer in moderate doses [33]
Valerian root Valerian extracts Used for anxiety and sleep; modest evidence [34]
Iron supplements Iron + B-vitamins Effective when deficiency is present [35]
Beef/blood tonics B12, iron, protein Components now understood individually [36]
Phosphorus compounds Phosphatidylserine Moderate evidence for cognitive support [37]

Sources [33-37]: Various pharmacological reviews

Why Brain Fog Isn't a Clinical Diagnosis (Yet)

Despite affecting a large share of adults, "brain fog" has no dedicated diagnostic code in any major classification system. This matters: without a code, there's no standardized tracking, limited insurance coverage, and fragmented research funding.

Current Classification Status

System Status What's Used Instead Source
ICD-10 No specific code R41.89 "Other symptoms and signs involving cognitive functions and awareness" [38]
ICD-11 Partial recognition MB20.2 "Clouding of consciousness" — includes "brain fog" as inclusion term [39]
DSM-5-TR Not recognized "Cognitive disorder not otherwise specified" or symptom of other conditions [40]

[38] WHO ICD-10; [39] WHO ICD-11; [40] APA DSM-5-TR

Why No Diagnosis? Three Barriers

1. Definition Problem

Researchers can't agree what brain fog is. A 2025 review in Trends in Neurosciences identified three competing definitions: (a) a single symptom, (b) a syndrome (bounded set of symptoms), or (c) an inherently ambiguous umbrella term. Without consensus, standardization is impossible. [41] Ross et al., Trends in Neurosciences, 2025

2. No Biomarker

Until 2024, there was no objective test for brain fog. The Trinity College Dublin study showing blood-brain barrier disruption on MRI may change this—but the imaging isn't yet standardized or widely available. [42] Greene et al., Nature Neuroscience, 2024

3. Symptom Overlap

Brain fog symptoms overlap substantially with depression, anxiety, fatigue, and sleep disorders. Clinicians often attribute cognitive complaints to these conditions rather than recognizing brain fog as distinct. [43] Trends in Neurosciences, 2025

"There's this idea in medicine that if we can't break a symptom down into a latinized medical term then we've failed. Instead, it just might be a reason to keep investigating."

— Colin Doherty, MD, Trinity College Dublin, National Geographic 2025 [44]

Every Condition Associated with Brain Fog

Brain fog isn't unique to Long COVID. It appears in over 20 conditions—some with prevalence rates exceeding 90%. This section catalogs every condition with documented brain fog as a symptom.

Condition Brain Fog Prevalence Common Name Source
POTS (Postural Orthostatic Tachycardia Syndrome) 96% [45]
ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) 85-89% [46]
Long COVID (U.S., non-hospitalized) 86% COVID brain fog [47]
Central Narcolepsy/Primary Hypersomnia 74-86% [48]
Fibromyalgia 70-80% Fibro fog [49]
Perimenopause 68% Menopause brain fog [50]
Traumatic Brain Injury 65% [51]
Chemotherapy 44-75% Chemo brain, chemo fog [52]
Lupus (SLE) 30-40% Lupus fog [53]
Multiple Sclerosis 40-65% MS cognitive fog [54]
Parkinson's Disease 20-50% [55]
Depression 85-94% [56]
Anxiety Disorders Common [57]
PTSD Common [58]
ADHD Common [59]
Hypothyroidism Common Thyroid brain fog [60]
Hashimoto's Thyroiditis Common [61]
Diabetes (Type 2) Common [62]
Ehlers-Danlos Syndrome Common [63]
Celiac Disease Common Gluten fog [64]
Inflammatory Bowel Disease >50% [65]
Chronic Pain Conditions 15-40% [66]
Lyme Disease Common Lyme brain [67]
Mold Exposure (CIRS) Common [68]
Sleep Apnea Common [69]
Pregnancy 50-80% Pregnancy brain, mom brain [70]
Anemia (Iron Deficiency) Common [71]

Sources: [45-46, 48] Trends in Neurosciences 2025; [47] Northwestern/Frontiers in Human Neuroscience 2026; [49] Duke Health; [50] Climacteric 2022; [51-52] Trends in Neurosciences 2025; [53] Duke Health; [54] National MS Society; [55] National Parkinson Foundation; [56] DSM-5; [57-59] Multiple studies; [60] Cleveland Clinic; [61-64] Multiple studies; [65] GI Study 2024; [66] Trends in Neurosciences 2025; [67-71] Multiple sources

The Common Thread

What connects these disparate conditions? Emerging research points to neuroinflammation, blood-brain barrier dysfunction, and immune dysregulation as shared mechanisms. Brain fog may be a final common pathway for many different insults to the brain.

The Biology: What's Actually Happening in the Brain

For decades, brain fog was dismissed as psychological. Recent research has identified concrete biological mechanisms—providing validation for millions of patients and opening pathways for treatment.

1. Blood-Brain Barrier Disruption Confirmed 2024

The blood-brain barrier (BBB) is a highly selective membrane that protects the brain from toxins, pathogens, and inflammatory molecules. A landmark 2024 study in Nature Neuroscience found that Long COVID patients with brain fog have significantly "leaky" blood-brain barriers.

Confirmed
BBB disruption visible on DCE-MRI in patients with brain fog vs. those without
TGFβ ↑
Elevated transforming growth factor-β uniquely elevated in brain fog patients

"For the first time, we have been able to show that leaky blood vessels in the human brain, in tandem with a hyperactive immune system may be the key drivers of brain fog."

— Matthew Campbell, PhD, Trinity College Dublin [74]

2. Neuroinflammation

When the immune system detects a threat, it produces inflammatory cytokines. In healthy people, this response resolves. In brain fog, inflammation persists—activating microglia (the brain's immune cells) and damaging neural tissue.

Microglia
Brain's immune cells become dysfunctional and start damaging neurological tissue
IL-1, IL-6 ↑
Inflammatory cytokines elevated in COVID-19 patients with cognitive symptoms

3. Coagulation Abnormalities

Brain fog patients show dysregulated clotting systems. Microclots may impair blood flow to the brain, reducing oxygen and nutrient delivery to neurons. [77] Pretorius et al., Cardiovascular Diabetology, 2021

4. Autoantibodies

Some patients produce autoantibodies that attack healthy brain tissue. This may explain why brain fog persists long after the initial trigger resolves. [78] Wallukat et al., Journal of Translational Medicine, 2021

5. Gut-Brain Axis Disruption

The gut microbiome communicates with the brain via the vagus nerve. Disruption of this axis—common after infection, antibiotic use, or dietary changes—may contribute to cognitive symptoms. [79] Cryan et al., Physiological Reviews, 2019

6. Mitochondrial Dysfunction

Mitochondria produce cellular energy. When they malfunction, neurons can't fire efficiently—leading to the subjective experience of mental sluggishness and excessive cognitive effort. [80] Picard et al., Nature Reviews Neuroscience, 2022

Economic Impact: The $5 Trillion Crisis

At the 2025 World Economic Forum in Davos, brain health emerged as a G7 priority for the first time. The reason: McKinsey Health Institute's estimate that brain health disorders now impose a staggering $5 trillion annual burden on the global economy.

$5 Trillion
Annual global cost of brain health disorders
$16 Trillion
Projected annual global cost by 2030

Note on McKinsey Projections

McKinsey's 2030 projections have varied across publications ($6T, $15T, $16T). The $16 trillion figure reflects their most recent estimate. All projections depend on methodology and which conditions are included under "brain health."

2–4 Million
Americans forced from workforce by Long COVID cognitive symptoms
$350,000
Average lifetime cost of dementia care per patient in the U.S.
70%
Share of dementia care costs borne by families, not insurance
$3.7 Trillion
Lost productivity from brain health conditions globally (included in $5T total)
[86] McKinsey Health Institute, 2025

International Comparisons: Brain Fog Across Borders

Brain fog is not just an American phenomenon—but how it's reported, recognized, and studied varies dramatically by country. Cultural factors, healthcare access, and stigma all shape how cognitive symptoms are acknowledged.

Note on International Data

International statistics should be interpreted with caution. Reporting rates reflect healthcare access, cultural attitudes toward cognitive symptoms, and diagnostic practices—not necessarily true underlying prevalence.

Long COVID Brain Fog by Country

Brain Fog Prevalence in Long COVID Patients (Non-Hospitalized)

United States
86%
Nigeria
63%
Colombia
62%
India
15%

Source: [87] Northwestern Medicine / Frontiers in Human Neuroscience, 2026

71.6%
of European adults 50+ experienced at least one long COVID symptom up to 12 months post-infection
−3 to −9 IQ
Cognitive deficit range in UK Biobank study (mild COVID to ICU admission), measured via online cognitive tasks

Correction Note

A previous version of this page cited "8–26% of UK adults reported impaired concentration in the REACT cohort" and attributed it to NEJM 2024. The Hampshire et al. study measured cognitive deficits via online tasks in the UK Biobank, not self-reported concentration in the REACT cohort. This stat has been removed pending identification of the correct source.

20.4%
Combined prevalence of mental health conditions and brain fog in long COVID globally (3-24 months)
10.6%
of older European adults with pre-existing depression reported persistent "confusion" (brain fog) after COVID

Root Causes: What's Driving the Crisis

The data points to a convergence of modern lifestyle factors—not a single pathogen or event. These factors overlap and compound each other.

Ultra-Processed Food

57-60%
of American calories come from ultra-processed foods
+16%
cognitive impairment risk per 10% increase in UPF consumption

Financial Stress

90%
of Americans report money as a source of stress
73%
say finances are their #1 source of stress

Loneliness

58%
of Americans report feeling lonely
50%
increased dementia risk from social isolation

Sleep Deprivation

35%
of American adults get less than 7 hours of sleep
70 Million
Americans suffer from chronic sleep disorders

Screen Time

7+ hours
average daily screen time for American adults
9 hours
average daily screen time for Gen Z

Gender, Hormones, and Brain Fog

Brain fog affects women more than men—and hormonal factors play a significant role.

OR 1.2
Women are 20% more likely to report brain fog than men
68%
of perimenopausal women report brain fog
60%
of menopausal women report memory problems
[104] North American Menopause Society
50-80%
of pregnant women report "pregnancy brain" symptoms
[105] Multiple studies

Perimenopause and Menopause

The transition to menopause involves dramatic changes in estrogen and progesterone—hormones that affect brain function. Many women experience their first significant cognitive symptoms during this period. Research suggests these symptoms often improve after menopause is complete—the transition period itself may be the most difficult.

Children and Teenagers: The Developing Brain at Risk

Brain fog is not just an adult phenomenon. Children and adolescents experience cognitive difficulties from multiple sources—and the developing brain may be particularly vulnerable.

Long COVID in Children

7%
of children report brain fog 12 months after COVID infection (Omicron variant)
2.4%
of children had persistent cognitive impairment at 3, 6, AND 12 months post-infection

Screen Time and the Adolescent Brain

9 hours
Average daily screen time for U.S. teenagers
[108] Common Sense Media
Thinner cortex
MRI differences seen in children with 7+ hours daily screen time

Sleep Deprivation in Adolescence

16%
of adolescents report trouble falling or staying asleep
28%
of adolescents have overall sleep disturbance

Long COVID: The Accelerant

Long COVID has brought unprecedented attention to brain fog—but it didn't create the phenomenon. The inflection point for cognitive decline was 2016. Long COVID has accelerated an existing trend.

~17 Million
Americans currently experiencing Long COVID
86%
of U.S. non-hospitalized Long COVID patients report brain fog as a primary symptom

Context for 86% Statistic

The 86% figure is from the U.S. cohort of a cross-continental comparison study of non-hospitalized patients. Rates varied significantly by country (63% Nigeria, 62% Colombia, 15% India), suggesting cultural and healthcare access factors influence reporting. The 20–65% range below reflects broader estimates across different study methodologies.

20-65%
Range of brain fog prevalence estimates in Long COVID (reflecting measurement inconsistency)
−6 IQ points
Average cognitive deficit in Long COVID patients (symptoms 12+ weeks)
[115] NEJM, 2024

Cognitive Impact by COVID Severity

Severity IQ Equivalent Drop Recovery Timeline Source
Mild COVID (resolved 4-12 weeks) −3 points Usually resolves within months [116]
Long COVID (symptoms 12+ weeks) −6 points Months to years; variable [117]
ICU admission −9 points May persist 42+ months [118]

Sources [116-118]: Hampshire et al., NEJM, 2024. Note: A previously listed "Hospitalized (not ICU): −7 points" category has been removed as it was not a separate breakdown in the original study.

What Brain Fog Actually Feels Like

Statistics capture the scale; phenomenology captures the texture. A 2023 study analyzed 717 first-person descriptions of brain fog from Reddit to understand what brain fog feels like to those experiencing it.

Experience % of Descriptions What It Means Source
Forgetfulness 36% Memory lapses, losing track of tasks [119]
Difficulty concentrating 30% Unable to focus, easily distracted [120]
Dissociation 24% Feeling "unreal," detached from self [121]
Cognitive slowness 18% Thoughts feel effortful, delayed [122]
Word-finding difficulties 16% Can't retrieve familiar words [123]
"Fuzziness" or pressure 7% Physical sensation of cloudiness [124]
Mental fatigue 6% Exhaustion from thinking [125]

Sources [119-125]: Reddit phenomenology study, 2023

"It feels like there's a bouncer in my head blocking my thoughts as I try to think and do things."

— Study participant, YoungMinds [126]

"Someone pulled the emergency brake in my brain while the world keeps moving around me."

— Study participant, Reddit analysis [127]

What Actually Works: Evidence-Based Interventions

Despite the scale of the crisis, evidence-based interventions exist. The strongest evidence supports lifestyle modifications — exercise, sleep, diet, and stress management — while targeted supplementation and clinical interventions show promising results for specific populations. Recommended reading - 54 ways to get rid of brain fog

Exercise Strong Evidence

29%
reduced dementia risk with regular physical activity
+2-3%
increase in hippocampal volume after 1 year of aerobic exercise

What the research recommends

150 minutes/week of moderate aerobic exercise (brisk walking, cycling, swimming) is the most consistently supported intervention for cognitive function. Exercise increases BDNF (brain-derived neurotrophic factor), promotes neurogenesis in the hippocampus, reduces neuroinflammation, and improves cerebrovascular health. Even a single 20-minute walk improves attention and working memory for several hours afterward.

Sleep Strong Evidence

7–9 hrs
optimal sleep duration for cognitive function — both too little and too much impair cognition
Large
effect size: even one night of sleep deprivation significantly impairs attention, working memory, and executive function

Why sleep is non-negotiable for brain fog

During deep sleep (N3/slow-wave), the glymphatic system clears metabolic waste — including amyloid-beta — from the brain. REM sleep consolidates memories and supports emotional processing. Chronic sleep restriction (even 1.5 hours less than optimal) produces cumulative cognitive deficits equivalent to total sleep deprivation. Consistent sleep/wake times matter as much as total hours: irregular schedules disrupt circadian regulation of cortisol, which directly impairs prefrontal cortex function.

Diet Strong Evidence

30-35%
reduced dementia risk with Mediterranean diet adherence
23%
reduced cognitive decline risk with MIND diet

Diet specifics that matter

Ultra-processed food consumption is independently associated with faster cognitive decline — a 10% increase in UPF intake correlates with measurably poorer executive function and memory scores. The MIND diet (a hybrid of Mediterranean and DASH) specifically targets brain health: leafy greens (6+ servings/week), berries (2+/week), nuts (5+/week), fatty fish (1+/week), and olive oil as the primary cooking fat. The mechanism involves reducing neuroinflammation, supporting blood-brain barrier integrity, and providing precursors for neurotransmitter synthesis.

Stress Management & Mindfulness Strong Evidence

111 RCTs
meta-analysis (n=9,538) found mindfulness-based interventions have small-to-moderate effects on global cognition, working memory, and sustained attention

How chronic stress drives brain fog

Chronic stress elevates cortisol, which directly impairs hippocampal function and prefrontal cortex activity — the exact brain regions responsible for memory encoding and executive function. Mindfulness-based stress reduction (MBSR) programs increase cortical thickness in attention-regulating brain regions and reduce amygdala reactivity. Even brief daily practices (10–15 minutes) show measurable improvements in sustained attention and working memory accuracy. Cognitive behavioral therapy for insomnia (CBT-I) is also strongly supported for stress-related cognitive symptoms.

Hydration Moderate Evidence

~2%
body water loss threshold at which cognitive performance begins to decline — most people don't notice dehydration at this level
Multiple studies — Adan (2012), Benton (2011)

Mild dehydration impairs short-term memory, attention, and psychomotor function before thirst is perceived. The brain is approximately 75% water; even modest fluid deficits reduce cerebral blood flow and increase fatigue. While individual needs vary, 2–3 liters/day of total fluid intake is a reasonable baseline for most adults — more in hot climates or with exercise.

Social Connection Moderate Evidence

50%
higher risk of dementia associated with social isolation

The 2024 Lancet Commission added social isolation as one of 14 modifiable risk factors for cognitive decline. Meaningful social engagement stimulates complex cognitive processing — conversation requires attention, memory retrieval, emotional regulation, and language production simultaneously. Loneliness increases systemic inflammation (elevated IL-6, CRP), which crosses the blood-brain barrier and contributes to neuroinflammation — one of the core mechanisms of brain fog.

Supplements With Evidence

Supplement Evidence Key Finding Dose Source
Omega-3 (DHA/EPA) Strong Improved memory, processing speed in multiple RCTs 1000–2000mg/day [132]
B-Complex Strong 84% improvement in B12-deficient patients Methylated forms [133]
Phosphatidylserine Moderate 2024 RCT: improved short-term memory 300mg/day [134]
Magnesium Moderate Higher intake → larger brain volumes 300–400mg/day [135]
Creatine Moderate Improved memory under stress/sleep deprivation 3–5g/day [136]
Huperzine A Moderate Meta-analysis of 20 RCTs: improved MMSE scores 200–400mcg/day [137]
Lion's Mane Emerging Small trials positive; NGF mechanism 500-3000mg/day [138]

Sources [132-138]: Various RCTs and meta-analyses. Supplements are not a substitute for lifestyle interventions. Consult a healthcare provider before starting any supplement regimen.

Disclosure: This database is published by SureOKGo. Our supplement FOG OFF contains Phosphatidylserine (200mg) and Huperzine A (60mcg) — both listed above — alongside Black Maca Root, L-Glutamic Acid, 5-HTP, Alpha Lipoic Acid, and Benfotiamine. Formulated by Dr. Alexandru-Theodor Amarfei, M.D. No statistic on this page promotes our products.

Clinical Interventions Emerging

For individuals with persistent brain fog that doesn't respond to lifestyle changes, several clinical approaches are under investigation or in early use:

Intervention Target Mechanism Status
Cognitive Behavioral Therapy (CBT) Maladaptive thought patterns, sleep, stress Established — effective for stress-related cognitive symptoms
Cognitive Rehabilitation Compensatory strategies for attention/memory Established in TBI/stroke — adapting for Long COVID
Low-Dose Naltrexone (LDN) Neuroinflammation, microglial modulation Phase 2 trials for Long COVID
Hyperbaric Oxygen Therapy Cerebral blood flow, tissue oxygenation Small RCTs showing improvement; larger trials ongoing
Transcranial Direct Current Stimulation Prefrontal cortex activation Promising pilot data; not yet standardized

The Hierarchy of Interventions

Start here → Sleep optimization + daily movement + anti-inflammatory diet form the foundation. These three alone resolve a significant proportion of brain fog cases. Then add → Stress management practices and social engagement. Consider → Targeted supplementation for specific deficiencies (B12, iron, vitamin D, omega-3). If persistent → Medical evaluation to rule out thyroid, autoimmune, or other underlying conditions. Cognitive rehabilitation and clinical interventions for refractory cases.

The Future: What's Coming for Brain Fog

For 175 years, brain fog has existed in a diagnostic limbo—real to those who experience it, but invisible to the medical establishment. That's changing.

Research Funding

$1.15 Billion
NIH RECOVER Initiative funding for Long COVID research (including cognitive symptoms)
Growing
UK, EU, and private foundations increasingly funding brain fog-specific research
[140] Multiple sources

Clinical Trials to Watch

Treatment Mechanism Trial Status Source
Bezisterim Anti-inflammatory; targets neuroinflammation Phase 2 trials [141]
Low-Dose Naltrexone (LDN) Immune modulation; reduces microglial activation Phase 2 trials [142]
Hyperbaric Oxygen Therapy Increases brain oxygenation; may repair BBB Small trials positive [143]
Photobiomodulation Near-infrared light; mitochondrial function Early trials [144]
Tocilizumab IL-6 inhibitor; reduces systemic inflammation Being studied for Long COVID [145]

Sources [141-145]: ClinicalTrials.gov and research publications

Measuring Brain Fog: The Brain Fog Scale

One reason brain fog has been difficult to study is the lack of standardized measurement. That changed in 2024 with the validation of the Brain Fog Scale (BFS)—the first dedicated self-report instrument.

The Brain Fog Scale (BFS)

Developed by Debowska et al. (2024) and validated in both Polish and English populations, the BFS is a 23-item self-report measure with three subscales:

Subscale Items What It Measures Source
Mental Fatigue 6 items Cognitive exhaustion, mental tiredness [146]
Impaired Cognitive Acuity 9 items Sharpness, clarity, processing speed [147]
Confusion 8 items Disorientation, difficulty following threads [148]

Sources [146-148]: Debowska et al., 2024

α > 0.90
Cronbach's alpha (high internal consistency) for the Brain Fog Scale
[149] Debowska et al., 2024
23 items
Total items in the validated Brain Fog Scale
[150] Debowska et al., 2024

Complete Source Index

Every statistic in this database is individually cited. Below is the full reference list with direct links to primary sources. Citations marked 📄 link to the original study or official page.

Section 1: Overview — The Crisis in Numbers

# Citation
[1] de Havenon A, et al. "Trends in Cognitive Disability in the United States, 2013–2023." Neurology, 2025. 📄 doi:10.1212/WNL.0000000000214226
[2–11] de Havenon A, et al. Neurology, 2025. Subgroup analyses: under-40, income, education, overall U.S. adult rates. 📄 Same source as [1]
[3] Drapała J, et al. "Brain Fog: Prevalence and Associated Factors." Frontiers in Human Neuroscience, 2024 (n=25,796). 📄 Full text

Section 2: History — From "Brain Fag" to Brain Fog

# Citation
[12] Ayonrinde OA. "'Brain Fag': A Syndrome Associated with 'Overstudy' and Mental Exhaustion in 19th Century Britain." International Review of Psychiatry, 2020. 📄 doi:10.1080/09540261.2020.1775428
[13] Dunglison R. A Dictionary of Medical Science, 1851. Entry for "brain-fag." Historical text — no digital link available.
[14] Beard GM. "Neurasthenia, or Nervous Exhaustion." Boston Medical and Surgical Journal, 1869; 80: 217–221. Historical text — referenced in 📄 Goetz, Neurology, 2001
[15–16] Ayonrinde OA. International Review of Psychiatry, 2020. Class distinctions and British Newspaper Archive analysis (83,479 references). 📄 Same source as [12]
[17] Mitchell SW. Fat and Blood: An Essay on the Treatment of Certain Forms of Neurasthenia and Hysteria, 1877. Historical text — available via 📄 Internet Archive
[18] Prince R. "The 'Brain Fag' Syndrome in Nigerian Students." Journal of Mental Science, 1960; 106: 559–570. 📄 PubMed
[19] American Psychiatric Association. DSM-III, 1980. Reference standard — available via APA Publishing.
[20] Multiple sources on fibro fog, chemo brain, and ME/CFS cognitive dysfunction in the 1990s.
[21] Taquet M, et al. "6-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19." The Lancet Psychiatry, 2021. 📄 Full text
[22] World Health Organization. ICD-10-CM code U09.9, "Post COVID-19 condition," 2021. 📄 WHO ICD-10
[23] Debowska A, et al. "Brain Fog Scale (BFS): Scale Development and Validation." Personality and Individual Differences, 2024; 216: 112427. 📄 ScienceDirect
[24] Greene C, et al. "Blood-brain barrier disruption in Long COVID-associated cognitive impairment." Nature Neuroscience, 2024. 📄 Full text
[25] de Havenon A, et al. Neurology, 2025. 📄 Same source as [1]
[26] Denno P, Zhao S, Husain M, Hampshire A. "Defining Brain Fog Across Medical Conditions." Trends in Neurosciences, 2025; 48(5). 📄 Full text (open access)

Section 3: Historical Treatments

# Citation
[27] Wessely S. "Old Wine in New Bottles: Neurasthenia and 'ME'." Psychological Medicine, 1990. 📄 Cambridge Core
[28] Mitchell SW. Fat and Blood, 1877. Direct quotation. 📄 Internet Archive
[29–30] Historical industry estimates: U.S. patent medicine market and product counts, circa 1900. Period sources — no digital link.
[31] Mariani Album and historical records: Vin Mariani endorsements and composition. Period sources.
[32] Coca-Cola Company archives: Pemberton's original "Brain Tonic" marketing. Historical records.
[33–37] Various pharmacological reviews on caffeine, valerian, iron, B12/protein, and phosphatidylserine. Multiple journal sources.

Section 4: Clinical Status — Still Not a Diagnosis

# Citation
[38] World Health Organization. ICD-10: Code R41.89, "Other symptoms and signs involving cognitive functions and awareness." 📄 WHO ICD-10 Browser
[39] World Health Organization. ICD-11: Code MB20.2, "Clouding of consciousness." 📄 WHO ICD-11 Browser
[40] American Psychiatric Association. DSM-5-TR. Brain fog not recognized as standalone diagnosis. Reference standard.
[41–43] Denno P, et al. "Defining Brain Fog Across Medical Conditions." Trends in Neurosciences, 2025. Three competing definitions, symptom overlap analysis. 📄 Same source as [26]
[42] Greene C, et al. Nature Neuroscience, 2024. 📄 Same source as [24]
[44] Doherty C, quoted in "What Is Brain Fog?" National Geographic, 2025. 📄 Article

Section 5: All Conditions Where Brain Fog Appears

# Citation
[45–46] Denno P, et al. Trends in Neurosciences, 2025. POTS (96%) and ME/CFS (85–89%). 📄 Same source as [26]
[47] Graham EL, et al. "Long COVID Brain Fog Far More Common in US Than India, Other Nations." Northwestern Medicine / Frontiers in Human Neuroscience, 2026. 📄 Press release
[48] Denno P, et al. Trends in Neurosciences, 2025. Narcolepsy/hypersomnia (74–86%). 📄 Same source as [26]
[49] Duke Health. "Fibromyalgia and Cognitive Dysfunction" (70–80%). 📄 Duke Health
[50] Gava G, et al. "Cognition, Mood and Sleep in Menopausal Transition." Climacteric, 2022. 📄 PubMed
[51–52] Denno P, et al. Trends in Neurosciences, 2025. TBI (65%) and chemotherapy (44–75%). 📄 Same source as [26]
[53] Duke Health. "Lupus/SLE Cognitive Dysfunction" (30–40%). 📄 Duke Health
[54] National Multiple Sclerosis Society. "MS Cognitive Fog" (40–65%). 📄 NMSS
[55] National Parkinson Foundation. "Parkinson's Cognitive Dysfunction" (20–50%). 📄 Parkinson.org
[56] American Psychiatric Association. DSM-5. Depression and cognitive symptoms (85–94%). Reference standard.
[57–59] Multiple studies on anxiety, PTSD, and ADHD cognitive dysfunction.
[60] Cleveland Clinic. "Hypothyroidism and Brain Fog." 📄 Cleveland Clinic
[61–64] Multiple studies on Hashimoto's, diabetes, EDS, and celiac disease cognitive symptoms.
[65] GI Study, 2024. Inflammatory bowel disease and cognitive dysfunction (>50%).
[66] Denno P, et al. Trends in Neurosciences, 2025. Chronic pain conditions (15–40%). 📄 Same source as [26]
[67–71] Multiple sources on Lyme disease, mold/CIRS, sleep apnea, pregnancy brain, and anemia cognitive symptoms.

Section 6: Mechanisms — What's Actually Happening in the Brain

# Citation
[72–74] Greene C, et al. "Blood-brain barrier disruption and neuroinflammation in Long COVID." Nature Neuroscience, 2024. Includes Campbell M quote. 📄 Full text
[75–76] "Microglial dysfunction and inflammatory cytokines in COVID-19." Nature Neuroscience, 2025. 📄 Full text
[77] Pretorius E, et al. "Persistent clotting protein pathology in Long COVID/PASC." Cardiovascular Diabetology, 2021; 20: 172. 📄 Full text (open access)
[78] Wallukat G, et al. "Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms." Journal of Translational Autoimmunity, 2021; 4: 100100. 📄 PubMed · 📄 PMC full text
[79] Cryan JF, et al. "The Microbiota-Gut-Brain Axis." Physiological Reviews, 2019; 99(4): 1877–2013. 📄 PubMed
[80] Picard M, et al. "Mitochondrial signal transduction." Cell Metabolism, 2022. 📄 PubMed

Section 7: Economic Impact

# Citation
[81] McKinsey Health Institute / World Economic Forum. "Youth Brain Health Crisis and Global Economy." 2025. 📄 WEF Article
[82] McKinsey Health Institute. "Adding Years to Life and Life to Years." 2025. 📄 Report
[83] Brookings Institution. "New Data Shows Long Covid Is Keeping as Many as 4 Million People Out of Work." 📄 Article
[84–85] Business Collaborative for Brain Health. "Brain Capital: A Business Imperative." 2025. 📄 Report
[86] McKinsey Health Institute, 2025. Lost productivity figures ($3.7T). 📄 Same source as [82]

Section 8: International Comparisons

# Citation
[87] Graham EL, et al. Northwestern Medicine / Frontiers in Human Neuroscience, 2026. Cross-country brain fog prevalence. 📄 Press release
[88] "Long COVID symptoms in European adults 50+." BMC Infectious Diseases, 2025. 📄 PubMed Central
[89] Hampshire A, et al. "Cognitive deficits in people who have recovered from COVID-19." NEJM, 2024. 📄 Full text
[90] BMC Infectious Diseases, 2025. Pre-existing depression and post-COVID confusion. 📄 Same source as [88]
[91] van der Feltz-Cornelis C, et al. "Prevalence of mental health conditions and brain fog in people with long COVID." General Hospital Psychiatry, 2024. 📄 Full text

Section 9: Root Causes — Beyond COVID

# Citation
[92] "Ultra-processed food consumption and health outcomes." BMJ, 2022. 📄 Full text
[93] "Ultra-processed food and cognitive decline." JAMA Neurology, 2022. 📄 Abstract
[94] Bankrate survey via CNBC, 2024. "90% of Americans Say Money Is a Source of Stress." 📄 Article
[95] American Psychological Association. "Stress in America" survey, 2024. 📄 Report
[96] Cigna. "The Loneliness Epidemic," 2024. 📄 Report
[97] Livingston G, et al. "Dementia prevention, intervention, and care." The Lancet Commission, 2024. 📄 Full text
[98–99] Centers for Disease Control and Prevention. Sleep and sleep disorders data, 2024. 📄 CDC data
[100] Statista. "Average daily screen time in the United States," 2024. 📄 Data
[101] Reviews.org. "Cell Phone Addiction," 2024. 📄 Report

Section 10: Gender Differences

# Citation
[102] Drapała J, et al. Frontiers in Human Neuroscience, 2024. Gender odds ratio for brain fog. 📄 Same source as [3]
[103] Gava G, et al. "Cognition, Mood and Sleep in Menopausal Transition." Climacteric, 2022. 📄 PubMed
[104] North American Menopause Society. Menopause and memory problems (60%). 📄 NAMS
[105] Multiple studies on "pregnancy brain" prevalence (50–80%).

Section 11: Children & Teens

# Citation
[106–107] CLoCk Study. "Long COVID cognitive symptoms in children." Brain, Behavior, and Immunity, 2024. 📄 Full text
[108] Common Sense Media. "The Common Sense Census: Media Use by Tweens and Teens." 📄 Report
[109] ABCD Study / NIH. Screen time and cortical thickness. 📄 Springer
[110–111] ABCD Study. Adolescent sleep disturbance prevalence, 2023. 📄 ScienceDirect

Section 12: Long COVID & Cognitive Impact

# Citation
[112] Kaiser Family Foundation. "Long COVID: What Do the Latest Data Show?" 2024. 📄 Brief
[113] Graham EL, et al. Northwestern Medicine / Frontiers in Human Neuroscience, 2026. U.S. non-hospitalized patients, 86% brain fog. 📄 Press release
[114] "What Is Brain Fog?" National Geographic, 2025. 📄 Article
[115–118] Hampshire A, et al. "Cognitive deficits in people who have recovered from COVID-19." NEJM, 2024. IQ deficit data by COVID severity. 📄 Full text

Section 13: The Lived Experience

# Citation
[119–125] Reddit phenomenology study, 2023. Analysis of 717 first-person brain fog descriptions. Academic study of user-generated content.
[126] YoungMinds study participant quote.
[127] Reddit phenomenology study participant quote.

Section 14: Evidence-Based Solutions

# Citation
[128] Livingston G, et al. The Lancet Commission, 2024. Exercise and dementia risk (29% reduction). 📄 Same source as [97]
[129] Erickson KI, et al. "Exercise training increases size of hippocampus." PNAS, 2011. 📄 PubMed
[130] "Mediterranean diet and cognitive decline." Geroscience, 2025. 📄 Full text
[131] Alzheimer's Association. MIND diet and cognitive decline risk. 📄 Alzheimer's Association
[132] Yurko-Mauro K, et al. "Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline." Alzheimer's & Dementia, 2010. 📄 PubMed
[133] Kennedy DO. "B Vitamins and the Brain." Nutrients, 2016; 8(2): 68. 📄 PubMed
[134] Glade MJ, Smith K. "Phosphatidylserine and the human brain." Nutrition, 2015; 31(6): 781–786. 📄 PubMed
[135] Boyle NB, et al. "The effects of magnesium supplementation on subjective anxiety and stress." Nutrients, 2017; 9(5): 429. 📄 PubMed
[136] Avgerinos KI, et al. "Effects of creatine supplementation on cognitive function." Experimental Gerontology, 2018; 108: 166–173. 📄 PubMed
[137] Yang G, et al. "Huperzine A for Alzheimer's disease: a systematic review." PLoS ONE, 2013; 8(9): e74916. 📄 PubMed
[138] Mori K, et al. "Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment." Phytotherapy Research, 2009; 23(3): 367–372. 📄 PubMed

Section 15: The Future of Brain Fog Research

# Citation
[139] NIH RECOVER Initiative. Long COVID research funding ($1.15B). 📄 Website
[140] Multiple sources on UK, EU, and private research funding for brain fog.
[141] ClinicalTrials.gov. Bezisterim for neuroinflammation. 📄 ClinicalTrials.gov
[142] ClinicalTrials.gov. Low-Dose Naltrexone for Long COVID. 📄 ClinicalTrials.gov
[143] ClinicalTrials.gov. Hyperbaric Oxygen Therapy for Long COVID cognitive symptoms. 📄 ClinicalTrials.gov
[144] ClinicalTrials.gov. Photobiomodulation for brain fog. 📄 ClinicalTrials.gov
[145] ClinicalTrials.gov. Tocilizumab (anti-IL-6) for Long COVID. 📄 ClinicalTrials.gov

Section 16: Measuring Brain Fog

# Citation
[146–150] Debowska A, et al. "Brain Fog Scale (BFS): Scale Development and Validation." Personality and Individual Differences, 2024; 216: 112427. Scale properties, subscales, and reliability data. 📄 ScienceDirect

A Note on Sources

Sources marked with 📄 link directly to the original study or official page. Historical sources (pre-digital publications from the 1800s–1960s) and aggregated statistics marked "Multiple sources" cannot be linked but are verifiable through academic databases like PubMed, Google Scholar, or institutional archives. If you need help locating a specific source, contact hi@sureokgo.com.

Overview: The Crisis Nobody Saw Coming

In October 2025, researchers from Yale School of Medicine published findings in Neurology that confirmed what millions had been experiencing: cognitive disability in America had risen dramatically—and the trend began years before anyone had heard of COVID-19. For a deeper look at What is brain fog? see our research overview.

7.4%
of U.S. adults now report cognitive disability — up from 5.3% in 2013 — [1] Yale/Neurology, 2025

"The trajectory suggests this increase began around 2016, preceding the COVID-19 pandemic."

— Adam de Havenon, MD, Yale School of Medicine

The inflection point was 2016—four years before SARS-CoV-2 emerged. While Long COVID has accelerated cognitive decline, it didn't create the crisis. Something else did: a convergence of ultra-processed diets, chronic stress, social isolation, screen saturation, and metabolic dysfunction.

~90%
Increase in cognitive disability among adults under 40 since 2013 (from 5.1% to 9.7%)
28.2%
of adults in a large survey report experiencing brain fog

Sample Note on 28.2% Statistic

This study surveyed users of a cognitive health app (Mindset Technologies). The sample was 89% female and self-selected — it may overestimate brain fog prevalence in the general population. The figure reflects self-reported brain fog among respondents, not a clinically diagnosed rate.

5.3% → 7.4%
Overall U.S. adult cognitive disability rate increase (2013–2023)
+40%
Overall increase in cognitive disability across all U.S. adults
Cognitive Disability Trends by Demographic (2013–2023)
Demographic 2013 Rate 2023 Rate Change Source
Overall U.S. adults 5.3% 7.4% +40% [6]
Adults under 40 5.1% 9.7% +90% [7]
Income under $35K 8.8% 12.6% +43% [8]
Income over $75K 1.8% 3.9% +117% [9]
No high school diploma 11.1% 14.3% +29% [10]
College degree 2.1% 3.6% +71% [11]

Sources [6-11]: Yale School of Medicine/Neurology, 2025

SureokGo proprietary compilation marker Gamma-2026-X7

🌏 Country Deep Dives

In-depth databases with country-specific research, cultural factors, and local statistics.

🇰🇷 South Korea

#1 OECD suicide rate · −13 IQ points lost to financial stress · 46.7% students sleep-deprived · ₩70T+ GDP lost annually

96 citations covering education pressure, digital dementia, household debt crisis, hagwon culture, and Hwa-byung.

→ View Full South Korea Database
🇬🇧 United Kingdom
Coming Q2 2026
🇯🇵 Japan
Coming Q2 2026
🎧 Want to deep dive? Listen to the podcast

Reference & Legal

How to Cite This Database

Quick Citation

Brain Fog Statistics Database 2026. SureokGo. Retrieved [date], from https://sureokgo.com/pages/brain-fog-statistics-2026

Citing Individual Statistics

[Statistic]. Source: Brain Fog Statistics Database 2026, SureokGo.com/pages/brain-fog-statistics-2026

Every statistic in this database is individually cited to its original peer-reviewed source. When citing a specific finding, we recommend citing both the original study and this database as the compilation source.

Usage Terms & Licensing

✓ Free Use (Encouraged)

  • Cite individual statistics with attribution in research, blog posts, articles
  • Screenshot and share on social media (URL included for credit)
  • Link to this database from your website or publication
  • Use in educational materials and presentations
  • Quote brief excerpts (under 100 words) with proper attribution

✗ Requires Permission

  • Republishing the entire database or substantial compilations
  • Creating competing "brain fog statistics" products or databases
  • Selling access to our data or including in paid products
  • Commercial use without licensing agreement
  • Automated scraping or bulk data extraction

License

This database compilation is © 2026 SureokGo, licensed under Creative Commons BY-NC-ND 4.0. For commercial licensing: hi@sureokgo.com

Methodology & Source Quality

This database synthesizes 150 statistics from peer-reviewed research, government health agencies, and established research institutions. We prioritize primary sources and cite every statistic to its original publication.

Primary Sources Include

  • Academic journals: Neurology, Nature Neuroscience, NEJM, JAMA Neurology, Lancet, BMJ, Frontiers in Human Neuroscience, Trends in Neurosciences, and others
  • Government agencies: CDC, NIH, WHO
  • Research institutions: Yale School of Medicine, Trinity College Dublin, Northwestern Medicine
  • Policy organizations: McKinsey Health Institute, Brookings Institution, Kaiser Family Foundation, World Economic Forum
  • Historical sources: Ayonrinde (2020), Dunglison (1851), Mitchell (1877), Prince (1960), Beard (1869)

Medical Review

Content reviewed for medical accuracy by Dr. Alexandru-Theodor Amarfei, M.D. — Senior consultant in geriatric medicine. Former chief of service. Post-covid recovery specialist. Inventor of FOG OFF.

Updates

This is a living database updated quarterly. Last updated: February 5, 2026. Next scheduled update: May 2026.

Spot an error? Contact: hi@sureokgo.com

Correction Log 13 fixes — Feb 5, 2026

Transparency matters. Here's every correction applied to this database:

Fix # Correction
1 Yale DOI corrected: 209940 → 214226 (all instances)
2 Date range corrected: "2011" → "2013" (all instances)
3 Under-40 stats: ~3%/~6%/+100% → 5.1%/9.7%/+90%
4 College stats: 2.5%/4.1%/+64% → 2.1%/3.6%/+71%
5 28.2% stat: Added sample caveat (89% female, app-based, not general pop)
6 IQ table: Removed "Hospitalized (not ICU): −7 points" row (not in NEJM study)
7 86% citation: Fixed link from PMC11191638 → Northwestern/Frontiers 2026
8 Journal name: "Frontiers in Neurology" → "Frontiers in Human Neuroscience"
9 86% stat: Added "U.S. non-hospitalized" qualifier + context callout
10 UK REACT "8-26%" stat: Removed (misattributed to NEJM Hampshire study)
11 McKinsey projection: $15T → $16T + caveat about projection inconsistencies
12 Removed unsourced "cost more than cancer/diabetes/heart disease combined" claim
13 Citation numbers renumbered after row removal in IQ table

150 citations · 17 sections · Updated quarterly

For informational and educational purposes only — not medical advice.

SureokGo.com · hi@sureokgo.com

© 2026 SureokGo. All rights reserved. Licensed under CC BY-NC-ND 4.0. See Usage Terms.

This compilation is the proprietary work of SureokGo. Database ID: BFS-2026-SOKG-7X9M2. Unauthorized reproduction is detectable. Contact hi@sureokgo.com for licensing.